Clinically, XRCC5 and XRCC6 single nucleotide polymorphisms as well as epigenetic silencing of these genes can lead to the development of multiple cancers, such as CRC, breast and lung cancer [47]. The gene discussed is XRCC5; the disease is colorectal carcinoma.